Hedge Fund

CLOUGH CAPITAL PARTNERS L P

Boston, MA SEC Registered Investment Advisor Institutional CIK: 0001276144
13F Score ?
5
3Y · Top 10 · Mgr Wt
13F Score ?
6
7Y · Top 10 · Mgr Wt
S&P 500 ?
80
Benchmark
$1.13B
AUM
+5.90%
2025 Q4
+7.47%
1-Year Return
+35.56%
Top 10 Concentration
+25.83%
Turnover
-1.40%
AUM Change
Since 2003
First Filing
109
# of Holdings

Fund Overview

13F Filed: 2026-02-17

As of 2025 Q4, Clough Capital Partners L P manages $1.13B in reported 13F assets , holds 109 positions with +35.56% top-10 concentration , and delivered a 1-year return of +7.47% on its disclosed equity portfolio. Filing 13F reports since 2003.

About

Investment Strategy

Analytics Summary

Risk Profile

Key Personnel

Charles I. Clough Jr. — Founder, Chairman & Chief Investment Officer
Eric Brock — Partner & Portfolio Manager
Robert Zdunczyk — Partner & Portfolio Manager
Official 13F Filings — SEC EDGAR Key personnel and Fund Overview may contain mistakes

Activity Summary — 2025 Q4

Q4 2025 13F Filed: Feb 17, 2026

Top Buys

% $
Stock % Impact
+2.78%
+1.71%
+1.50%
+1.48%
+1.27%
+1.17%

Top Sells

% $
Stock % Impact
-2.64%
Sold All 😨 Was: 2.43% -2.47%
Sold All 😨 Was: 1.82% -1.84%
-1.83%
Sold All 😨 Was: 1.69% -1.72%
-1.67%

Top Holdings

2025 Q4
Stock %
5.06%
4.83%
3.57%
3.40%
3.37%
3.35%
View All Holdings

Activity Summary

Latest
Market Value $1.13B
AUM Change -1.40%
New Positions 33
Increased Positions 33
Closed Positions 34
Top 10 Concentration +35.56%
Portfolio Turnover +25.83%
Alt Turnover +26.55%

Sector Allocation Trends

Quarterly History
Free View: Last 10 Quarters. Subscribe to see full history

Holdings Analysis

Size: % of Portfolio Color: Last Full-Quarter Return No data
Free: 10 quarters

Positions Dynamics

Visualizing Top 20 holdings weight history over the last 10 quarters.

Portfolio Analytics — Latest

CLOUGH CAPITAL PARTNERS L P risk dashboard covering volatility, beta, value-at-risk, drawdowns, concentration, factor tilts, benchmark comparison, and stress testing for the latest disclosed portfolio.

Risk access
Building institutional risk profile...
Guru Intelligence Hub Pro
Real-time Analytics
High-Conviction Alpha
AAPL 92.4
NVDA 88.1
MSFT 74.3
Strategy Guardian
Style Drift 0.12
Sector Rotation 0.38

Tracking institutional benchmark deviation

Scenario Lab
2008 GFC -32.4%
Covid-19 -18.1%
2022 Bear -24.7%
Unlock the full Guru Intelligence Hub
Real conviction scores for every holding  ·  Strategy Guardian alerts  ·  Live Scenario Lab stress tests
Upgrade to Pro

Best Strategy vs. Benchmarks

AI Backtest: Auto-Optimizing...
Loading AI Backtest...
Don't be Fooled by Randomness
Access Alpha, Capture Ratios, and Batting Average calibrated for this specific strategy.
UPGRADE NOW
Nassim Taleb — author of Fooled by Randomness
Returns
--
Latest Quarter
--
1-Year Return
--
Ann. Return
Risk
--
Std Deviation
--
Max Drawdown
--
Beta vs SPY
Quality
--
Sharpe
--
Sortino
--
Win Rate
--
Payoff Ratio
Edge Metrics Last 10 quarters only
--
Alpha annualized
--
Up Capture
--
Down Capture

Strategy Backtester: CLOUGH CAPITAL PARTNERS L P

Replicate top holdings performance • Compare vs benchmarks • Optimize N

Find the best N! Test multiple portfolio sizes at once to discover the optimal configuration.

Risk insights! Identify periods when the fund lagged the benchmark – critical for timing entries.

⏱ Run Backtest

Liquid Glass Edition

0
Backtests Run
+127%
Avg. Return

👆 Click the button to launch tickers!

Don't Be Fooled by Randomness
Proven alpha spans cycles, not just 24 months. Unlock full history since 1999.
PRO ACCESS
Free Demo
Try the Backtester on Real Funds
Run full-history backtests on a curated 2-3 funds. See signal quality, drawdowns, and cycle behavior before you decide.
Underperformance Analysis — Top 10 Holdings vs SPY

Backtesting CLOUGH CAPITAL PARTNERS L P's top 10 holdings against SPY identified 71 underperformance periods. Worst drawdown: 2020-02 – 2020-03 (-19.6% vs SPY, 2 quarters). Currently underperforming.

Avg. lag: -5.4% vs SPY Avg. duration: 1.9 quarters
Backtest Snapshot — Top 10 Holdings (Mn-Weighted)

The ticker-level breakdown shows how each of CLOUGH CAPITAL PARTNERS L P's top holdings contributed to portfolio returns quarter by quarter. Strongest recent contributors inside the last 5 years of the quarterly Top 10 backtest window: MSFT (2021 Q2 – 2025 Q3, +7.5 pts), GOOG (2022 Q2 – 2025 Q3, +5.4 pts), NVDA (2022 Q1 – 2025 Q3, +3.9 pts), DKNG (2023 Q2 – 2023 Q3, +3.9 pts), CCL (2021 Q1 – 2025 Q3, +3.9 pts) .

Strategy ann.: 8.0% SPY ann.: 10.3% Period: 2004–2026
Best Recent Contributors — Last 5Y
2 of 5 recent top contributors lagged SPY, which means even some of this fund's best return drivers still failed to beat a simple index over the same window.
2021 Q2 – 2025 Q3 • 18Q in Top 10 Lagged SPY
MSFT
+34%
SPY
+63%
Contrib
+7.5%
2022 Q2 – 2025 Q3 • 11Q in Top 10 Lagged SPY
GOOG
+20%
SPY
+45%
Contrib
+5.4%
2022 Q1 – 2025 Q3 • 6Q in Top 10 Beat SPY
NVDA
+52%
SPY
+24%
Contrib
+3.9%
2023 Q2 – 2023 Q3 • 2Q in Top 10 Beat SPY
DKNG
+49%
SPY
+12%
Contrib
+3.9%
2021 Q1 – 2025 Q3 • 11Q in Top 10 Beat SPY
CCL
+41%
SPY
+41%
Contrib
+3.9%
Stock return (green = beat SPY)   Stock return (red = lagged SPY)   SPY same period   Cumulative contribution during the last 5 years of the quarterly Mn-weighted Top 10 strategy

Frequently Asked Questions

What does Clough Capital Partners L P invest in?
Clough Capital Partners employs a growth-oriented investment strategy distinguished by its integration of global macroeconomic themes with fundamental equity research. The firm's approach reflects Charles Clough's background as a market strategist, emphasizing identification of secular trends and cyclical inflection points that create asymmetric investment opportunities. The **Sector Allocation History** reveals persistent emphasis on healthcare, technology, and financial services—sectors where the firm has developed particular analytical expertise. Within healthcare, Clough Capital has historically pursued opportunities in biotechnology and pharmaceuticals, seeking companies positioned to benefit from demographic trends and innovation cycles. Technology allocations reflect thematic views on digital transformation, cloud computing, and emerging platforms. Portfolio construction demonstrates willingness to take concentrated positions when conviction is high, while maintaining sufficient diversification to manage idiosyncratic risk. The **Top 10 Holdings Concentration** metric illuminates how aggressively the firm weights its highest-conviction ideas relative to broader diversification. This concentration approach aligns with the firm's active management philosophy and willingness to deviate meaningfully from benchmark weightings. Clough Capital also maintains flexibility to express bearish views and hedge market exposure, reflecting its hedge fund structure and macro orientation. This tactical flexibility distinguishes the firm from long-only managers and influences its capital trajectory characteristics during periods of market stress.
What is Clough Capital Partners L P's AUM?
Clough Capital Partners L P reported $1.13B in 13F assets as of 2025 Q4. Note: 13F AUM reflects only long equity positions reported to the SEC and may differ from total assets under management.
How concentrated is Clough Capital Partners L P's portfolio?
Clough Capital Partners L P holds 109 disclosed positions. The top 10 holdings represent +35.56% of the reported portfolio, indicating a diversified investment approach.
How to track Clough Capital Partners L P 13F filings?
Track Clough Capital Partners L P's quarterly filings on SEC EDGAR or on this page — data is updated within days of each filing deadline. Subscribe to 13Foresight for position-change alerts.
Who manages Clough Capital Partners L P?
Clough Capital Partners L P is managed by Charles I. Clough Jr. (Founder, Chairman & Chief Investment Officer), Eric Brock (Partner & Portfolio Manager), Robert Zdunczyk (Partner & Portfolio Manager).

Disclaimer: 13Foresight is not a registered investment adviser, broker-dealer, or financial planner. All information on this site is provided solely for informational and educational purposes and does not constitute investment advice, a solicitation, or a recommendation to buy or sell any security. Portfolio backtests shown on this page are hypothetical and simulated — they do not represent actual trading results and were constructed with the benefit of hindsight. Actual results would differ materially. 13F filings disclose only long equity positions valued above $10,000, submitted up to 45 days after quarter-end; they do not capture short positions, options, bonds, cash, private investments, or non-U.S. securities. A fund's backtest performance may not reflect its actual returns, as managers frequently generate alpha through strategies not visible in 13F data. Past performance is not indicative of future results. All data sourced from public SEC EDGAR filings. Use at your own risk. Full Terms of Use.

Full history →